Trial intelligence / Profile preview

Comparison of Vagiclean vaginal tablet and metronidazole for bacterial vaginosis

IRCT20220512054829N1Phase 3Completed

Sponsor
Kashan University of Medical Sciences
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Kashan University of Medical Sciences. Started May 2022; status: completed.

02

Drugs

metronidazole
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on IRCT20220512054829N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220512054829N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call